196 related articles for article (PubMed ID: 36829085)
1. Diagnostic yield of whole-body
Saleh JK; Barkmeier D; Frey KA; Davenport MS
J Nucl Cardiol; 2023 Oct; 30(5):1773-1781. PubMed ID: 36829085
[TBL] [Abstract][Full Text] [Related]
2. The Utility of Whole Body
Giudicatti L; Marangou J; Nolan D; Dembo L; Baumwol J; Dwivedi G
Heart Lung Circ; 2020 Jan; 29(1):e1-e6. PubMed ID: 31501049
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases.
Braun JJ; Kessler R; Constantinesco A; Imperiale A
Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1537-43. PubMed ID: 18418595
[TBL] [Abstract][Full Text] [Related]
4. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
5. Utility of new FDG-PET/CT guidelines for diagnosing cardiac sarcoidosis in patients with implanted cardiac pacemakers for atrioventricular block.
Tanabe S; Nakano Y; Ando H; Fujimoto M; Onishi T; Ohashi H; Kuno S; Naito K; Waseda K; Takahashi H; Suzuki Y; Fukuta M; Amano T
Sci Rep; 2024 Apr; 14(1):7825. PubMed ID: 38570621
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
Okada T; Kawaguchi N; Miyagawa M; Matsuoka M; Tashiro R; Tanabe Y; Kido T; Miyoshi T; Higashi H; Inoue T; Okayama H; Yamaguchi O; Kido T
J Nucl Cardiol; 2023 Feb; 30(1):280-289. PubMed ID: 35804283
[TBL] [Abstract][Full Text] [Related]
7.
Chauvelot P; Skanjeti A; Jamilloux Y; de Parisot A; Broussolle C; Denis P; Ramackers JM; Giammarile F; Kodjikian L; Seve P
Br J Ophthalmol; 2019 Nov; 103(11):1650-1655. PubMed ID: 30658987
[TBL] [Abstract][Full Text] [Related]
8. Same day comparison of PET/CT and PET/MR in patients with cardiac sarcoidosis.
Wisenberg G; Thiessen JD; Pavlovsky W; Butler J; Wilk B; Prato FS
J Nucl Cardiol; 2020 Dec; 27(6):2118-2129. PubMed ID: 30603887
[TBL] [Abstract][Full Text] [Related]
9.
Young KA; Lyle M; Rosenbaum AN; Chang IC; Lin G; Bois MC; Ezzeddine OFA; Jouni H; Chareonthaitawee P; Kapa S; Grogan M; Cooper LT; Blauwet L; Bois JP
J Nucl Cardiol; 2023 Apr; 30(2):726-735. PubMed ID: 35084701
[No Abstract] [Full Text] [Related]
10. Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
J Nucl Cardiol; 2020 Dec; 27(6):2103-2115. PubMed ID: 30603894
[TBL] [Abstract][Full Text] [Related]
11. F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Weinberg RL; Morgenstern R; DeLuca A; Chen J; Bokhari S
J Nucl Cardiol; 2017 Dec; 24(6):2015-2018. PubMed ID: 27197820
[TBL] [Abstract][Full Text] [Related]
12. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Greulich S; Gatidis S; Gräni C; Blankstein R; Glatthaar A; Mezger K; Müller KAL; Castor T; Mahrholdt H; Häntschel M; Hetzel J; Dittmann H; Nikolaou K; Gawaz M; la Fougère C; Krumm P
JACC Cardiovasc Imaging; 2022 Mar; 15(3):445-456. PubMed ID: 34656480
[TBL] [Abstract][Full Text] [Related]
13. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
14.
Demaria L; Borie R; Benali K; Piekarski E; Goossens J; Palazzo E; Forien M; Dieudé P; Crestani B; Ottaviani S
Clin Rheumatol; 2020 Sep; 39(9):2727-2734. PubMed ID: 32198555
[TBL] [Abstract][Full Text] [Related]
15. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis.
Ohira H; Tsujino I; Ishimaru S; Oyama N; Takei T; Tsukamoto E; Miura M; Sakaue S; Tamaki N; Nishimura M
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):933-41. PubMed ID: 18084757
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of quantitative assessment of cardiac
Lebasnier A; Legallois D; Bienvenu B; Bergot E; Desmonts C; Zalcman G; Agostini D; Manrique A
Ann Nucl Med; 2018 Jun; 32(5):319-327. PubMed ID: 29560563
[TBL] [Abstract][Full Text] [Related]
17. Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
Peretto G; Busnardo E; Ferro P; Palmisano A; Vignale D; Esposito A; De Luca G; Campochiaro C; Sartorelli S; De Gaspari M; Rizzo S; Dagna L; Basso C; Gianolli L; Della Bella P; Sala S
JACC Cardiovasc Imaging; 2022 Oct; 15(10):1771-1780. PubMed ID: 36202457
[TBL] [Abstract][Full Text] [Related]
18. Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
Rojulpote C; Bhattaru A; Jean C; Adams SL; Patel V; Vidula MK; Selvaraj S; Dubroff J; Peyster E; Clancy CB; Patterson K; Marchlinski FE; Rossman M; Goldberg L; Bravo PE
JACC Cardiovasc Imaging; 2022 Nov; 15(11):1944-1955. PubMed ID: 36357136
[TBL] [Abstract][Full Text] [Related]
19. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
